| Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice JJ Fuster, S MacLauchlan, MA Zuriaga, MN Polackal, AC Ostriker, ... Science 355 (6327), 842-847, 2017 | 1150 | 2017 |
| Regulation of vascular smooth muscle cell differentiation EM Rzucidlo, KA Martin, RJ Powell Journal of vascular surgery 45 (6), A25-A32, 2007 | 517 | 2007 |
| Aldose reductase, oxidative stress, and diabetic mellitus WH Tang, KA Martin, J Hwa Frontiers in pharmacology 3, 87, 2012 | 468 | 2012 |
| Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation SX Gu, T Tyagi, K Jain, VW Gu, SH Lee, JM Hwa, JM Kwan, DS Krause, ... Nature Reviews Cardiology 18 (3), 194-209, 2021 | 397 | 2021 |
| Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection M Farzan, H Choe, K Martin, L Marcon, W Hofmann, G Karlsson, Y Sun, ... The Journal of experimental medicine 186 (3), 405-411, 1997 | 376 | 1997 |
| The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1 H Choe, M Farzan, M Konkel, K Martin, Y Sun, L Marcon, M Cayabyab, ... Journal of Virology 72 (7), 6113-6118, 1998 | 292 | 1998 |
| Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity R Liu, Y Jin, WH Tang, L Qin, X Zhang, G Tellides, J Hwa, J Yu, KA Martin Circulation 128 (18), 2047-2057, 2013 | 291 | 2013 |
| A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 M Farzan, H Choe, L Vaca, K Martin, Y Sun, E Desjardins, N Ruffing, L Wu, ... Journal of virology 72 (2), 1160-1164, 1998 | 289 | 1998 |
| The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation KA Martin, EM Rzucidlo, BL Merenick, DC Fingar, DJ Brown, RJ Wagner, ... American Journal of Physiology-Cell Physiology 286 (3), C507-C517, 2004 | 287 | 2004 |
| Coordinate regulation of translation by the PI 3-kinase and mTOR pathways KA Martin, J Blenis Academic Press 86, 1-39, 2002 | 280 | 2002 |
| p70 S6 kinase is regulated by protein kinase Cζ and participates in a phosphoinositide 3-kinase-regulated signalling complex A Romanelli, KA Martin, A Toker, J Blenis Molecular and cellular biology 19 (4), 2921-2928, 1999 | 239 | 1999 |
| HIV-1 entry and macrophage inflammatory protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5 M Farzan, H Choe, KA Martin, Y Sun, M Sidelko, CR Mackay, NP Gerard, ... Journal of Biological Chemistry 272 (11), 6854-6857, 1997 | 237 | 1997 |
| Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways L Liu, F Li, JA Cardelli, KA Martin, J Blenis, S Huang Oncogene 25 (53), 7029-7040, 2006 | 226 | 2006 |
| Epigenetic regulation of smooth muscle cell plasticity R Liu, KL Leslie, KA Martin Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (4), 448-453, 2015 | 172 | 2015 |
| Utilization of CC chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239 L Marcon, H Choe, KA Martin, M Farzan, PD Ponath, L Wu, W Newman, ... Journal of virology 71 (3), 2522-2527, 1997 | 170 | 1997 |
| Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling KA Martin, BL Merenick, M Ding, KM Fetalvero, EM Rzucidlo, CD Kozul, ... Journal of biological chemistry 282 (49), 36112-36120, 2007 | 166 | 2007 |
| New targets to treat obesity and the metabolic syndrome KA Martin, MV Mani, A Mani European journal of pharmacology 763, 64-74, 2015 | 164 | 2015 |
| Cardioprotective prostacyclin signaling in vascular smooth muscle KM Fetalvero, KA Martin, J Hwa Prostaglandins & other lipid mediators 82 (1-4), 109-118, 2007 | 155 | 2007 |
| Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition E Arehart, J Stitham, FW Asselbergs, K Douville, T MacKenzie, ... Circulation research 102 (8), 986-993, 2008 | 150 | 2008 |
| Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy JR McMullen, T Shioi, L Zhang, O Tarnavski, MC Sherwood, AL Dorfman, ... Molecular and cellular biology, 2004 | 141 | 2004 |
